Hello Readers!
To follow up our 200% winner (UCHC) from yesterday, we found an awesome company with plenty of upside. And it isn’t often you see or hear about an OTC company that most of Wall St. has praise for.
BICX is getting their positive attention for good reason! ….We’ll get to the technical stuff in a moment, for now let’s tell you about the company.
BICX or BioCorRx, Inc., is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction.
BICX has developed a revolutionary alcohol treatment program with an 85% success rate, as reported by patients that have completed the program and completed routine telephone and face-to-face interviews.
BioCorRx’s proven approach to defeating addiction delivers life-changing results.
The Start Fresh Program that BICX offers is a comprehensive treatment program that significantly reduces or eliminates the physical cravings for alcohol and opiates through the use of a time-release implant containing the drug, naltrexone. With cravings out of the way, patients can address the reasons for their addiction through their personalized program.
Now, we all know the harmful effects of alcohol and the dangers its abuse can have on individuals and families.
Alcohol treatment and rehabilitation is in huge demand today as alcohol addiction becomes a bigger cause for concern in today's society.
BICX has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug naltrexone.
After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opiates for as long as a year in some patients, depending on individual metabolism rates and other factors.
Furthermore, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings for alcohol continue to remain greatly reduced or even eliminated.
As much as we don’t want to admit it, alcohol and drug addictions exist all around us and all over the world. BICX is paving the way for everyone with an addiction for a fresh start.
Don’t look at this as possibly making a profit on people’s problems or shortcomings. It should be looked at as scientific advancement and a better future for all of society.
The healthcare sector of business is never going to go away and it is only getting bigger.
BICX is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.
BICX intends to distribute the Start Fresh Program to a new clinic in the United States every 60 to 90 days. (There are over 11,000 treatment centers in USA alone and over 38 million Americans with alcohol addiction.) Clinics using their program are also holding discussions with major health insurance providers in their respective areas to pay for all or a portion of the treatment fees. Some clinics have already been successful in receiving payments from insurance providers!
This program has already been launched and BICX is the captain of the ship! Their views and procedures are second to none to anyone else in the industry.
Not only that, but the news keeps coming and coming and coming. March 2015 has been one of the busiest months. Check out all the links below and see how active this company really is and how aggressive they are at advancing forward.
March 9: http://finance.yahoo.com/news/biocorrx-inc-mylife-recovery-centerstm-110000396.html
March 12: http://finance.yahoo.com/news/biocorrx-inc-enters-supply-agreement-120000466.html
March 18: http://finance.yahoo.com/news/biocorrx-inc-announces-reinstatement-letter-120000788.html
March 23: http://finance.yahoo.com/news/wealthmakers-com-initiates-coverage-biocorrx-123000570.html
BUSINESS SUMMARY
(BICX - BioCorRx, Inc.)
BioCorRx, Inc. is a healthcare company on the leading edge of addiction treatment. The company has developed a treatment program called the Start Fresh Program that is used by various licensed addiction clinics throughout the United States. The program consists of two components: BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and other substances for several months and as long as a year in some patients, depending on individual metabolism rates. BioCorRx also owns a life-coaching program that is tailored specifically to alcoholics and some other addictions. Once a patient has received the implant, they are encouraged to enter the life-coaching program to maximize results. BioCorRx's revolutionary treatment program has a very high success rate as reported by patients to the clinics that use the program in routine interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life-coaching program without co-workers or family members knowing, unless they so choose.
MARKET OUTLOOK
The U.S.outpatient rehabilitation market is estimated to be a $19 billion industry with a projected annual growth rate of five percent or higher. The sector is also highly fragmented, with no company controlling significant market share.
Source: http://corporate.usph.com/corporate/industry-overview.aspx
Favorable legislation and a recovering economy will support revenue growth. Moreover, the improving economic environment is forecast to boost revenue for the Drug and Alcohol Rehabilitation Clinics industry during the five years to 2020. The Patient Protection and Affordable Care Act (PPACA) of 2010 is expanding private and government coverage of industry services, thereby bolstering demand. In turn, companies will continue to enter the industry due to an increasing focus on outpatient services, which are less costly than inpatient care and more desirable among insurance providers, supporting revenue growth.
Source: http://www.ibisworld.com/industry/drug-alcohol-rehabilitation-clinics.html
Drug, alcohol and other addiction rehab in the United States is big business - $35 billion this year. There are now 14,000+ treatment facilities and growing. A total of 2.5 million persons received treatment, but many more need it and facilities are filled to capacity. However, insurance coverage for rehab is limited. As a result, most of the tab is paid by government/state agencies.
Source: http://www.marketwatch.com/story/the-us-addiction-rehab-industry-2014-08-04-52033057
INVESTOR HIGHLIGHTS
BICX looks like a safe play with huge potential upside.
BICX’s chart gives us the assumption that the current up climb we’re witnessing could be the initial stages of its forecasted breakout.
BICX is uniquely poised to gain significant market share in the $35 billion annual alcohol and drug treatment market in the US.
BioCorRx intends to distribute the Start Fresh Program to a new clinic in the United States every 60 to 90 days.
BICX completed a large buyback and retirement in 2012 of 27 million shares and retirement of outstanding common stock.
BICX became cash flow positive in 2014 for the first time in its history due to increase in license fees, royalties and direct sales.
Now it’s up to you to look into this any further. Start your own research now. See the facts for yourself.
These markets can sometimes be very quick and volatile so use caution and always stay alert. Happy trading!
